Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 4 (3 bromopropyl) methyl benzoate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112321425B details a novel two-step one-pot synthesis for methyl 4-(3-bromopropyl) benzoate, offering significant cost reduction and scalability for osteoporosis drug intermediates.